Sort by
Refine Your Search
-
towards biomarkers of brain function” (NewPaths). The IP of the project are Dr. Jordi Vilaplana and Dr. Carme Pelegrí. The research group is formed by the 2 IP, one associate professor, one tenure-elegible
-
, led by the University of Barcelona, contributes to these objectives through: Methodological development of advanced isotope techniques, with a focus on compound‑specific isotope analysis (CSIA) for CECs
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
professional development and work with the technology transfer office to identify potential inventions and understand IP processes. Collaborate in preclinical and translational research projects involving murine
-
technology transfer office to identify potential inventions and understand IP processes. Coordinate and perform preclinical experimental work related to LAMA2-RD therapy development. Establish, maintain and